« Previous
Next »
Journal of the American Society of Hypertension
Volume 2, Issue 4,
Supplement
, Pages
S16-S22
, July 2008
24-hour powerful blood pressure-lowering: is there a clinical need?
-
Changes in SBP control in the 24 hours after a missed dose of telmisartan 80 mg or valsartan 160 mg in patients with mild-to-moderate hypertension (the MICADO I and II studies). SBP, systolic blood pr
Changes in SBP control in the 24 hours after a missed dose of telmisartan 80 mg or valsartan 160 mg in patients with mild-to-moderate hypertension (the MICADO I and II studies). SBP, systolic blood pressure. Reproduced with permission from Lacourciere Y, Krzesinski JM, White WB, Davidai G, Schumacher H. Sustained antihypertensive activity of telmisartan compared with valsartan. Blood Press Monit 2004;9:203–10.32
-
Changes in 24-hour, daytime, nighttime, and morning SBP following treatment with telmisartan plus HCTZ or amlodipine plus HCTZ (the ATHOS [A comparison of Telmisartan plus HCTZ with amlodipine plus HCChanges in 24-hour, daytime, nighttime, and morning SBP following treatment with telmisartan plus HCTZ or amlodipine plus HCTZ (the ATHOS [A comparison of Telmisartan plus HCTZ with amlodipine plus HCTZ in Older patients with predominantly Systolic hypertension] Study). HCTZ, hydrochlorothiazide; SBP, systolic blood pressure. Reproduced with permission from Neldam S, Edwards C, ATHOS Study Group. Telmisartan plus HCTZ vs. amlodipine plus HCTZ in older patients with systolic hypertension: results from a large ambulatory blood pressure monitoring study. Am J Geriatr Cardiol 2006;15:151–60.33
Conflict of interest: none.
PII: S1933-1711(08)00038-7
doi: 10.1016/j.jash.2008.03.004
© 2008 American Society of Hypertension. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of the American Society of Hypertension
Volume 2, Issue 4,
Supplement
, Pages
S16-S22
, July 2008
